Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial.
March 11, 2025
The study conducted by Clemens W. Janssen and colleagues investigated the effects of whole-body hyperthermia (WBH) on individuals with major depressive disorder (MDD). In a randomized, double-blind, controlled trial, 30 participants were treated with either active WBH or a sham condition that mimicked all aspects of WBH except the application of intense heat. The primary outcome measure was the Hamilton Depression Rating Scale (HDRS), assessed at multiple points following the intervention. The results demonstrated that the WBH group experienced significantly greater reductions in HDRS scores compared to the sham group, with improvements sustained for up to six weeks after the intervention. These findings suggest that WBH, which can be delivered through infrared saunas or similar heat-based therapies, may provide a rapid-acting and sustained antidepressant effect in patients with MDD.
This study underscores the potential of infrared saunas as an effective alternative or adjunct to traditional antidepressant treatments. By utilizing whole-body hyperthermia, the research shows that thermal therapy may reduce depressive symptoms by influencing physiological mechanisms such as circulation, stress response, and neurochemistry. The success of WBH in this trial positions it as a promising, non-pharmacological treatment option for depression, particularly given the growing need for safe and effective therapies that are well-tolerated by patients. The research was led by a team of experts from various institutions, including the University of Arizona, Harvard Medical School, and the University of California, Los Angeles, among others.
